Our Team

Andrew Paul, CEO

Andrew Paul, CEO

Mr. Paul is an experienced entrepreneur who oversees the business practices of the company, including contracting, financial management, and internal business structures. Prior to starting, operating then selling his own company, Capitol Impact LLC., he worked for divisions of Dun & Bradstreet and VNU. He is experienced with profit-based business practices and finding talent.

Thomas Kusch, MS, PhD, Chief Scientist

Thomas Kusch, MS, PhD

Dr. Kusch joined the company in July 2022, with more than 20 years of experience in laboratory research work that included characterizing cancer biomarkers, principal investigator of a research lab at Rutgers University where he identified novel subunits of cancer-related enqyme complexes and their modulators and started his own business to investigate cell-based cancer diagnostics and therapeutic assays. During that time, he developed broad technical expertise in laboratory management, diagnostic procedure and protocols, cell culture, flow cytometry, and biochemical assays. At MMG, he has day-to-day responsibility for study design and execution to meet the goals of the company’s funded projects. He completed his Ph.D. at Eberhard-Karls-University Tübingen, Germany, and his MS at University of Cologne, Germany.